Somatic mutations in acute promyelocytic leukemia (APL) identified by exome sequencingGREIE, P. A; YAGHMAIE, M; BOHLANDER, S. K et al.Leukemia. 2011, Vol 25, Num 9, pp 1519-1522, issn 0887-6924, 4 p.Article

Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies : Myeloid biologyCHOU, Wen-Chien; DANG, Chi V.Current opinion in hematology. 2005, Vol 12, Num 1, pp 1-6, issn 1065-6251, 6 p.Article

Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemiaBATZIOS, Crisoula; HAYES, Lachlan A; HE, Simon Z et al.American journal of hematology. 2009, Vol 84, Num 11, pp 715-719, issn 0361-8609, 5 p.Article

Advances in therapies for acute promyelocytic leukemiaKAMIMURA, Tomohiko; MIYAMOTO, Toshihiro; HARADA, Mine et al.Cancer science. 2011, Vol 102, Num 11, pp 1929-1937, issn 1347-9032, 9 p.Article

Acute promyelocytic leukemia : from highly fatal to highly curableWANG, Zhen-Yi; ZHU CHEN.Blood. 2008, Vol 111, Num 5, pp 2505-2515, issn 0006-4971, 11 p.Article

Suppressive effects of statins on acute promyelocytic leukemia cellsSASSANO, Antonella; KATSOULIDIS, Efstratios; ANTICO, Giovanni et al.Cancer research (Baltimore). 2007, Vol 67, Num 9, pp 4524-4532, issn 0008-5472, 9 p.Article

Case 2. Right ventricular lesion as presenting feature of acute promyelocytic leukemiaPOTENZA, Leonardo; LUPPI, Mario; MORSELLI, Monica et al.Journal of clinical oncology. 2004, Vol 22, Num 13, pp 2742-2744, issn 0732-183X, 3 p.Article

Secondary acute myeloid leukemia occurring after successful treatment of acute promyelocytic leukemiaJUNFA CHEN; ZHIYIN ZHENG; JIANPING SHEN et al.International journal of hematology. 2012, Vol 95, Num 3, pp 327-328, issn 0925-5710, 2 p.Article

Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic triode in frontline therapyCHENDAMARAI, Ezhilarasi; BALASUBRAMANIAN, Poonkuzhali; CHANDRAN NAIR, Sukesh et al.Blood. 2012, Vol 119, Num 15, pp 3413-3419, issn 0006-4971, 7 p.Article

Acute Promyelocytic Leukemia in Patients Aged Over 60 Years: Multicenter Experience of 34 Consecutive Unselected PatientsFERRARA, Felicetto; FINIZIO, Olimpia; D'ARCO, Alfonso et al.Anticancer research. 2010, Vol 30, Num 3, pp 967-971, issn 0250-7005, 5 p.Article

Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemiaJIN ZHOU; YINGMEI ZHANG; YANHONG ZHAO et al.Blood. 2010, Vol 115, Num 9, pp 1697-1702, issn 0006-4971, 6 p.Article

Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experienceADES, Lionel; GUERCI, Agnes; TOURNILHAC, Olivier et al.Blood. 2010, Vol 115, Num 9, pp 1690-1696, issn 0006-4971, 7 p.Article

Management of acute promyelocytic leukemia : recommendations from an expert panel on behalf of the European LeukemiaNetSANZ, Miguel A; GRIMWADE, David; BURNETT, Alan K et al.Blood. 2009, Vol 113, Num 9, pp 1875-1891, issn 0006-4971, 17 p.Article

Recurrent Acute Promyelocytic Leukemia Presenting As a Sacral Nerve Root MassKESARI, Santosh; DRAPPATZ, Jan; AKAR, Serra et al.Journal of clinical oncology. 2008, Vol 26, Num 19, pp 3279-3281, issn 0732-183X, 3 p.Article

Treatment of newly diagnosed acute promyelocytic leukemia (APL) : a comparison of French-Belgian-Swiss and PETHEMA resultsADES, Lionel; SANZ, Miguel A; RAYON, Consuelo et al.Blood. 2008, Vol 111, Num 3, pp 1078-1084, issn 0006-4971, 7 p.Article

Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemiaDALAL, Bakul I; BRUYERE, Helene; BARNETT, Michael J et al.British journal of haematology. 2007, Vol 137, Num 5, pp 385-385, issn 0007-1048, 1 p.Article

Targeting APL fusion proteins by peptide interferenceMELNICK, A.Current Topics in Microbiology and Immunology. 2007, Vol 313, pp 221-243, issn 0070-217X, 23 p.Article

Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia : durable remissions with minimal toxicity. CommentaryDOUER, Dan; MATHEWS, Vikram; CHANDY, Mammen et al.Blood. 2006, Vol 107, Num 7, issn 0006-4971, 2588-2589,2627-2632 [8 p.]Article

Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemiaNICCI, C; OTTAVIANI, E; TESTONI, N et al.Leukemia. 2005, Vol 19, Num 3, pp 470-472, issn 0887-6924, 3 p.Article

Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experienceADES, L; CHEVRET, S; GARO, C et al.Leukemia. 2005, Vol 19, Num 2, pp 230-233, issn 0887-6924, 4 p.Article

Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemiaSANZ, Miguel A; TALLMAN, Martin S; LO-COCO, Francesco et al.Blood. 2005, Vol 105, Num 8, pp 3019-3025, issn 0006-4971, 7 p.Article

The expression of telomeric proteins and their probable regulation of telomerase during the differentiation of all-trans-retinoic acid-responsive and -resistant acute promyelocytic leukemia cellsJIE SUN; HE HUANG; YUANYUAN ZHU et al.International journal of hematology. 2005, Vol 82, Num 3, pp 215-223, issn 0925-5710, 9 p.Article

Acute promyelocytic leukemia, microgranular variantBLOOD, Many.Blood. 2004, Vol 104, Num 3, issn 0006-4971, p. 605Article

Analysis of p73 expression pattern in acute myeloid leukemias: lack of ΔN-p73 expression is a frequent feature of acute promyelocytic leukemiaRIZZO, M. G; GIONIHINI, E; DIVERIO, D et al.Leukemia. 2004, Vol 18, Num 11, pp 1804-1809, issn 0887-6924, 6 p.Article

Retinoid target genes in acute promyelocytic leukemiaPITHA-ROWE, I; PETTY, W. J; KITAREEWAN, S et al.Leukemia. 2003, Vol 17, Num 9, pp 1723-1730, issn 0887-6924, 8 p.Article